At the recent 4th World Psoriasis & Psoriatic Arthritis Conference, the International Federation of Psoriasis Associations (IFPA) released the results of a global survey on significant unmet needs on the impact of psoriasis.
Over 4,600 individuals completed the survey between June 2014 and May 2015, which was designed to gain insight into most valuable tools to improve treatment and education of psoriasis. Tools that were rated highest were the following:
- Educating the patients about treatment options
- Educating the patients about psoriasis as a serious, inflammatory, noncommunicable disease
- Educating policy makers about the socioeconomic (both for the individual and society at large) and psychosocial impact of psoriasis (depression, stigmatization, discrimination)
- Educating the patients about serious comorbid conditions (psoriatic arthritis, metabolic syndrome, type 2 diabetes, cardiovascular disease, psychosocial impacts, etc.)
- Educating doctors and other healthcare professionals about treatment options
Lars Ettarp, President of the IFPA, noted that the results reflect a gap in the patient as a priority and as the focus of strategic activities. Efforts are needed to strengthen activities in this specific area so that the necessary education reaches the patients, the healthcare professionals and policy makers.
For more information visit IFPA-PSO.org.
This article originally appeared on MPR